If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
168.20    1.80 (1.08%)
Bid:
169.00
Ask:
169.60
Spread: 0.60 (0.355%)
Market Cap: £204.68m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Notice of GM

5 Sep 2025 07:00

RNS Number : 0979Y
SThree plc
05 September 2025
 

5 September 2025

STHREE PLC

Publication of Circular and Notice of General Meeting

As noted in the financial results of SThree Plc (the "Company") for the six months ended 31 May 2025 (the "Results Announcement"), the Directors have determined that certain distributions, being the FY24 interim dividend paid 6 December 2024, the FY24 final dividend paid 6 June 2025, and the share buyback programme undertaken from December 2024 to May 2025 (together, the "Relevant Distributions"), did not comply fully with the technical requirements of the Companies Act 2006 (the "Act"). The Group as a whole has, at all times, had sufficient profits and other distributable reserves to pay the Relevant Distributions, however the Company itself had insufficient distributable reserves at the time the Relevant Distributions were made.

As noted in the Results Announcement, this issue only impacts the prior Relevant Distributions mentioned above, and there is no change to the financial outlook of the Company as a consequence. The matter has no impact on the Company's intentions or ability to continue returning capital to shareholders in line with its capital allocation policy. The Company's past accounts will not need to be restated and no repayments are expected in respect of any of the Relevant Distributions.

The approach that the Company is proposing to address the situation outlined below is consistent with the approach taken by other listed companies that have encountered similar issues in the past.

The Board has taken steps to remedy the situation and the Company will today publish and make available to shareholders a circular (the "Circular") containing a notice convening a general meeting at which a special resolution will be proposed which will, if passed, address the situation and put all potentially affected parties back in the position they were intended to be had the full technical requirements of the Act been complied with at the time the Relevant Distributions were made, including by authorising the appropriation of the distributable profits of the Company to the payment of the Relevant Distributions.

The general meeting of the Company is being convened for 11.00 a.m. on 1 October 2025 at Level 16, 8 Bishopsgate, London, England, EC2N 4BQ.

The Circular contains details of the proposals for the Company to enter into certain deeds of release in respect of the claims it may have against past and present shareholders who were recipients of the Dividends to repay the amounts so received, and against persons who were directors of the Company at the time of payment of the Dividends and entry into the Buy-backs (the "Relevant Directors").

The entry by the Company into a deed of release in respect of the claims it may have in connection with the Relevant Distributions against the Relevant Directors constitutes a related party transaction (as defined in the UK Listing Rules). Accordingly, as provided for in UK Listing Rule 8.2.1R, the Board has obtained an opinion from Investec and Berenberg , acting in their capacity as joint sponsor to the Company, that each of: (i) the waiver of claims in connection with the Dividends and the Buy-backs against the Relevant Directors; and (ii) the entry into a deed of release for such purpose, are fair and reasonable so far as the shareholders of the Company are concerned.

As the Buy-backs were conducted at a time when the Company did not have sufficient distributable profits, title to the shares which were the subject of such buybacks has not transferred to the Company from Investec or Berenberg who were acting as the Company's brokers in relation to the Buy-backs. The Company is therefore also proposing, and seeking approval from shareholders at the General Meeting, to enter into a deed with each of Investec and Berenberg in order, inter alia, to effect the lawful transfer of the shares that were subject of the Buy-backs, thereby transferring equitable title in the relevant shares from each of them (as appropriate) to the Company.

In accordance with UK Listing Rule 6.4.1, a copy of the Circular will be submitted to the National Storage Mechanism and will shortly be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism  and on the Company's website, https://www.sthree.com/en-gb/investor-centre/

Capitalised terms used but not otherwise defined in this announcement have the meaning given to them in the Circular.

Enquiries

SThree plc

Timo Lehne, CEO

via Alma

Andrew Beach, CFO

Keren Oser, Investor Relations Director

Charlie Hildesley, Investor Relations Manager 

 

Alma Strategic Communications

+44 20 3405 0205

 

SThree@almastrategic.com  

Rebecca Sanders-Hewett  

Hilary Buchanan

Sam Modlin

Will Ellis Hancock 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGPKQBPPBKDNCK
Date   Source Headline
6th Jul 20264:18 pmRNSHolding(s) in Company
3rd Jul 202610:02 amRNSHolding(s) in Company
3rd Jul 20267:00 amRNSTransaction in Own Shares
1st Jul 202610:42 amRNSTotal Voting Rights
26th Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20263:28 pmRNSHolding(s) in Company
19th Jun 20267:00 amRNSTransaction in Own Shares
18th Jun 20264:46 pmRNSHolding(s) in Company
16th Jun 20265:15 pmRNSDirector/PDMR Shareholding
16th Jun 20267:00 amRNSFY26 Half Year Trading Update
15th Jun 202612:41 pmRNSChair tenure extension
15th Jun 202612:33 pmRNSDirector/PDMR Shareholding
12th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20269:53 amRNSHolding(s) in Company
5th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20265:25 pmRNSHolding(s) in Company
1st Jun 202612:29 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
26th May 20264:00 pmRNSHolding(s) in Company
26th May 20269:30 amRNSHolding(s) in Company
22nd May 20263:00 pmRNSDirector/PDMR Shareholding
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
12th May 20265:16 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20269:51 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20263:30 pmRNSHolding(s) in Company
29th Apr 202612:20 pmRNSResult of AGM
24th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202610:35 amRNSHolding(s) in Company
14th Apr 202610:29 amRNSHolding(s) in Company
13th Apr 20264:45 pmRNSDirector/PDMR Shareholding
13th Apr 20263:38 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:14 pmRNSHolding(s) in Company
7th Apr 20269:30 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:18 pmRNSTotal Voting Rights
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20262:37 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:37 pmRNSPurchase of shares into the EBT
17th Mar 20269:50 amRNSHolding(s) in Company
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.